Condition
Renal Impairments
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (3)
P 4 (1)
Trial Status
Completed4
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07034768Phase 1CompletedPrimary
A Study to Evaluate EDG-7500 in People With Renal Impairment
NCT07445906Phase 1Not Yet RecruitingPrimary
A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment
NCT07241494Not ApplicableCompletedPrimary
Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment.
NCT05012436Phase 1Completed
A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects
NCT01491113Phase 4Completed
Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients
Showing all 5 trials